Kimberly-Clark stock (US4943681035): Recent earnings beat and strong dividend yield

Kimberly-Clark reported quarterly EPS of $1.97, topping estimates by $0.04, with revenue up 2.7% year-over-year. The stock offers a 5.27% dividend yield after 54 years of increases.

Kimberly-Clark, the maker of Kleenex, Huggies and Kotex, delivered better-than-expected quarterly results, posting earnings per share of $1.97 against a consensus of $1.93. Revenue rose 2.7% year-over-year for the period reported on MarketBeat as of recent data. This performance underscores the company's resilience in consumer staples amid economic shifts, appealing to US investors seeking stability.

As of: 14.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Kimberly-Clark Corporation
• Sector/industry: Consumer Staples / Household Products
• Headquarters/country: Irving, Texas, USA
• Core markets: North America, global in 175 countries
• Key revenue drivers: Tissue, diapers, feminine care, professional products
• Home exchange/listing venue: Nasdaq (KMB)
• Trading currency: USD

Kimberly-Clark: core business model

Kimberly-Clark Corporation manufactures and markets personal care and consumer tissue products worldwide. Its portfolio includes well-known brands like Kleenex tissues, Huggies diapers, Kotex feminine care, Cottonelle wipes and Scott bathroom tissue, as detailed on MarketBeat company overview. The company operates through segments such as consumer tissue, baby and child care, adult care, and professional solutions, serving retail, healthcare and institutional customers.

Founded in 1872 in Neenah, Wisconsin, and now headquartered in Irving, Texas, Kimberly-Clark has grown into a global leader with 36,000 employees. It emphasizes innovation, supply-chain efficiency and marketing to maintain market share in essential goods, which are less sensitive to economic cycles.

Main revenue and product drivers for Kimberly-Clark

Key revenue comes from personal care products like diapers and training pants under Huggies, feminine care via Kotex and incontinence items. Tissue products, including facial and bathroom tissues, contribute significantly, alongside professional hygiene solutions under KleenGuard. Annual sales reached $16.45 billion for the latest reported period, per MarketBeat financials.

The company's dividend strength stands out, with a 5.27% yield ranking in the top 25% of payers and 54 consecutive years of increases. Payout ratio is 80.38%, supported by cash flow of $9.96 per share.

Industry trends and competitive position

In the consumer staples sector, Kimberly-Clark competes with Procter & Gamble and Unilever in household essentials. Demand for hygiene and personal care remains steady, bolstered by aging populations driving adult care growth. The firm's focus on innovation helps counter private-label pressures in US retail channels.

Why Kimberly-Clark matters for US investors

Listed on Nasdaq as KMB, Kimberly-Clark provides US investors exposure to defensive staples with strong North American revenue. Its products are staples in US households and businesses, offering stability amid market volatility. Market cap stands at $32.22 billion, with a P/E ratio of 15.24.

Conclusion

Kimberly-Clark's recent earnings beat and robust dividend history highlight its position as a reliable player in consumer essentials. With a global footprint and focus on innovation, the company navigates sector challenges effectively. US investors track its performance for defensive qualities in portfolios.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.